首页> 外文期刊>Emerging Infectious Diseases >Decreasing Shigellosis-related Deaths without Shigella spp.–specific Interventions, Asia
【24h】

Decreasing Shigellosis-related Deaths without Shigella spp.–specific Interventions, Asia

机译:在没有志贺氏菌属特定干预措施的情况下减少与志贺菌病有关的死亡,亚洲

获取原文
获取外文期刊封面目录资料

摘要

In 1999, a review of the literature for 1966–1997 sug-gested that ≈ 1.1 million persons die annually of shigellosis, including ≈ 880,000 in Asia. Our recent review of the litera-ture for 1990–2009 indicates that ≈125 million shigellosis cases occur annually in Asia, of which ≈14,000 are fatal. This estimate for illnesses is similar to the earlier estimate, but the number of deaths is 98% lower; that is, the lower es-timate of deaths is associated with markedly reduced case-fatality rates rather than fewer cases. Shigella spp.–related deaths decreased substantially during a period without Shi-gella spp.–specifi c interventions. We speculate that non-specifi c interventions, e.g., measles vaccination, vitamin A supplementation, and improved nutrition, may have led to the reduced number of shigellosis-related deaths
机译:在1999年,对1966-1997年文献的回顾表明,每年约有110万人死于志贺氏菌病,其中包括亚洲的约880,000人。我们最近对1990-2009年文学的回顾表明,亚洲每年发生约1.25亿例志贺菌病病例,其中约有1.4万人死亡。此疾病估计与先前的估计相似,但死亡人数降低了98%;也就是说,较低的死亡率估计与病死率显着降低有关,而不是与较少的病例有关。在没有施氏杆菌属特定干预措施的时期内,与志贺氏菌相关的死亡显着减少。我们推测,非特异性干预措施(例如麻疹疫苗接种,维生素A补充和营养改善)可能导致与志贺菌病相关的死亡人数减少

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号